Latest News | Yaz, Yasmin & Ocella Lawyers
January 11, 2012 Update
Wall Street Journal article states certain FDA advisors had undisclosed ties to Bayer surrounding Yaz December Safety Committee Recommendations.
October 27, 2011 Update
The United States FDA published a report concluding that Yaz and Yasmin increases the risk of blood clots by almost 75%.
October 25, 2011 Update
The British Medical Journal released a research paper concluding that Yaz and Yasmin containing Drospirenone increases the risk of venous thromboembolism (VTE) by 100% compared to other oral contraceptives.
September 26th, 2011 Update
The FDA formally issued a Safety Alert again publicizing its continued concern regarding the side effects from the use of Yaz / Yasmin / Ocella including Pulmonary Embolisms, D.V.T.’s, U.T.E.’s, Strokes and Gall Bladder disease.
We are representing over 500 Yaz / Yasmin and Ocella victim in all 50 states who have suffered from pulmonary embolism, deep vein thrombosis, strokes, VTE, and gall bladder problems.
Please contact us today if you or a loved one suffered one of these side effects from Yaz.
